Adi Gilboa-Geffen

13 papers and 742 indexed citations i.

About

Adi Gilboa-Geffen is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Adi Gilboa-Geffen has authored 13 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Pharmacology and 2 papers in Immunology. Recurrent topics in Adi Gilboa-Geffen’s work include Cholinesterase and Neurodegenerative Diseases (6 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Adi Gilboa-Geffen is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (6 papers), Nicotinic Acetylcholine Receptors Study (4 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Adi Gilboa-Geffen collaborates with scholars based in Israel, United States and Germany. Adi Gilboa-Geffen's co-authors include Hermona Soreq, Yochai Wolf, David Greenberg, Iftach Shaked, Ari Meerson, Yehuda Pollak, Gunther Hartmann, Lee Adam Wheeler, Judy Lieberman and Raz Yirmiya and has published in prestigious journals such as Blood, Immunity and PLoS ONE.

In The Last Decade

Co-authorship network of co-authors of Adi Gilboa-Geffen i

Fields of papers citing papers by Adi Gilboa-Geffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adi Gilboa-Geffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adi Gilboa-Geffen. The network helps show where Adi Gilboa-Geffen may publish in the future.

Countries citing papers authored by Adi Gilboa-Geffen

Since Specialization
Citations

This map shows the geographic impact of Adi Gilboa-Geffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adi Gilboa-Geffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adi Gilboa-Geffen more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025